These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21845075)

  • 1. A novel preparation method for camptothecin (CPT) loaded folic acid conjugated dextran tumor-targeted nanoparticles.
    Zu Y; Wang D; Zhao X; Jiang R; Zhang Q; Zhao D; Li Y; Zu B; Sun Z
    Int J Mol Sci; 2011; 12(7):4237-49. PubMed ID: 21845075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of camptothecin (CPT)-loaded folate-conjugated dextran nanoparticles for tumor-targeted drug delivery using supercritical antisolvent method.
    Zhao X; Wang D; Zu Y; Jiang R; Zhao D; Li Y; Zu B; Sun Z; Zhang Q
    J Control Release; 2011 Nov; 152 Suppl 1():e90-2. PubMed ID: 22195950
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparation and physicochemical properties of 10-hydroxycamptothecin (HCPT) nanoparticles by supercritical antisolvent (SAS) process.
    Zhao X; Zu Y; Jiang R; Wang Y; Li Y; Li Q; Zhao D; Zu B; Zhang B; Sun Z; Zhang X
    Int J Mol Sci; 2011; 12(4):2678-91. PubMed ID: 21731466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.
    Li Q; Liu C; Zhao X; Zu Y; Wang Y; Zhang B; Zhao D; Zhao Q; Su L; Gao Y; Sun B
    Int J Nanomedicine; 2011; 6():397-405. PubMed ID: 21499429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Stability and Oral Bioavailability of Folic Acid-Dextran-Coenzyme Q
    Luo M; Yang X; Ruan X; Xing W; Chen M; Mu F
    J Agric Food Chem; 2018 Sep; 66(37):9690-9696. PubMed ID: 30141926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity.
    Esfandyari-Manesh M; Darvishi B; Ishkuh FA; Shahmoradi E; Mohammadi A; Javanbakht M; Dinarvand R; Atyabi F
    Mater Sci Eng C Mater Biol Appl; 2016 May; 62():626-33. PubMed ID: 26952466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Process optimization for the preparation of oligomycin-loaded folate-conjugated chitosan nanoparticles as a tumor-targeted drug delivery system using a two-level factorial design method.
    Zu Y; Zhao Q; Zhao X; Zu S; Meng L
    Int J Nanomedicine; 2011; 6():3429-41. PubMed ID: 22267927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.
    Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y
    Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loading studies of the anticancer drug camptothecin into dual stimuli-sensitive nanoparticles. Stability scrutiny.
    Iglesias N; Galbis E; Díaz-Blanco MJ; de-Paz MV; Galbis JA
    Int J Pharm; 2018 Oct; 550(1-2):429-438. PubMed ID: 30196142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luminescent/magnetic hybrid nanoparticles with folate-conjugated peptide composites for tumor-targeted drug delivery.
    Shen JM; Guan XM; Liu XY; Lan JF; Cheng T; Zhang HX
    Bioconjug Chem; 2012 May; 23(5):1010-21. PubMed ID: 22486419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Techniques to develop and characterize nanosized formulation for salbutamol sulfate.
    Bhavna ; Ahmad FJ; Khar RK; Sultana S; Bhatnagar A
    J Mater Sci Mater Med; 2009 Dec; 20 Suppl 1():S71-6. PubMed ID: 18543087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model.
    Chao P; Deshmukh M; Kutscher HL; Gao D; Rajan SS; Hu P; Laskin DL; Stein S; Sinko PJ
    Anticancer Drugs; 2010 Jan; 21(1):65-76. PubMed ID: 19966540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin.
    Li C; Zhang D; Guo H; Hao L; Zheng D; Liu G; Shen J; Tian X; Zhang Q
    Int J Pharm; 2013 May; 448(1):79-86. PubMed ID: 23518367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
    Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S
    Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, formula optimization and antitumor actions of mannitol coupling camptothecin nanoparticles.
    Wang Z; Li Q; Zhao X; Sun B; Zhu Q; Gao W; Hua C
    Int J Pharm; 2014 Apr; 465(1-2):360-7. PubMed ID: 24530520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
    Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supercritical antisolvent co-precipitation of rifampicin and ethyl cellulose.
    Djerafi R; Swanepoel A; Crampon C; Kalombo L; Labuschagne P; Badens E; Masmoudi Y
    Eur J Pharm Sci; 2017 May; 102():161-171. PubMed ID: 28302396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dextran vesicular carriers for dual encapsulation of hydrophilic and hydrophobic molecules and delivery into cells.
    Pramod PS; Takamura K; Chaphekar S; Balasubramanian N; Jayakannan M
    Biomacromolecules; 2012 Nov; 13(11):3627-40. PubMed ID: 23082727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy.
    Kılıçay E; Demirbilek M; Türk M; Güven E; Hazer B; Denkbas EB
    Eur J Pharm Sci; 2011 Oct; 44(3):310-20. PubMed ID: 21884788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.